Fig. 1From: Clinical efficacy and safety of polymyxins based versus non-polymyxins based therapies in the infections caused by carbapenem-resistant Acinetobacter baumannii: a systematic review and meta-analysisA PRISMA flow chart of study selectionBack to article page